Sigilon Therapeutics, Inc.
SGTX · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,506 | -$7,378 | -$6,685 | -$8,671 |
| Dep. & Amort. | $310 | $315 | $315 | $316 |
| Deferred Tax | $205 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,559 | $1,349 | $1,210 | $1,342 |
| Change in WC | $289 | -$6,716 | -$3,044 | -$3,898 |
| Other Non-Cash | $987 | $1,028 | $987 | $923 |
| Operating Cash Flow | -$4,156 | -$11,402 | -$7,217 | -$9,988 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$139 | -$351 | -$25 | -$6 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$6,892 | $0 | $42,524 | -$1,484 |
| Inv. Sales/Matur. | $6,875 | $12,589 | $18,000 | $9,750 |
| Other Inv. Act. | $48 | $0 | -$42,471 | $8 |
| Investing Cash Flow | -$108 | $12,238 | $18,028 | $8,268 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $25 | $61 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$17,369 | -$1,642 | -$1,667 | $13 |
| Financing Cash Flow | -$17,369 | -$1,642 | -$1,667 | $13 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$21,633 | -$806 | $9,144 | -$1,707 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $42,544 | $43,350 | $34,206 | $35,913 |
| End Cash | $20,911 | $42,544 | $43,350 | $34,206 |
| Free Cash Flow | -$4,295 | -$11,753 | -$7,242 | -$9,994 |